The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU ® (trastuzumab deruxtecan) as a monotherapy for adult patients with HER2 ...
Vanda Pharmaceuticals had 9% revenue growth and heavy losses with a 1.4x sales valuation and a PDUFA date. Check out why VNDA ...
Johnson & Johnson today announced new results from the Phase 1b/2 OrigAMI-4 study showing that first-line treatment with investigational subcutaneous amivantamab and hyaluronidase-lpuj in combination ...
Johnson & Johnson (NYSE:JNJ) today announced new results from the Phase 1b/2 OrigAMI-4 study showing that first-line treatment with investigational subcutaneous amivantamab and hyaluronidase-lpuj in ...
Boehringer Ingelheim recently announced that 2 of its products, NexGard and NexGard COMBO, received Emergency Use Authorization (EUA) for treating New World screwworm (NWSW) myiasis in both feline and ...
Accounting for Silver, Copper, Lead and Zinc within these 54 drill hole results, Goliath reports an average 13.2% increase in overall grade ...
Accounting for Silver, Copper, Lead and Zinc within these 54 drill hole results, Goliath reports an average 13.2% increase in ...
The USDA announced it has granted Emergency Use Authorization (EUA) to afoxolaner chewable tablets (NexGard;Boehringer Ingelheim) for treating New World screwworm (NWS) myiasis in canines, and ...